Page 19 - Viral Vector News Today

Researchers from the Federal University of Paraná, Brazil, looked into the seroconversion rate after vaccination with the CoronaVac. Using immunoassays, they measured the immunoglobulins (IgG) for anti-nucleocapsid protein (anti-N) antibodies and anti-spike-1 (anti-S1) protein antibodies.

A panel of experts at the online pharma event discussed how the pandemic created opportunities for the field but could also lead to significant challenges.

Novasep expands in France, sees increasing customer demand for ADC manufacturing services Novasep has announced a further expansion of its Highly Potent Active Pharmaceutical Ingredients (HPAPIs) manufacturing capabilities at its Le Mans, France site, saying the move strengthens its position as a leading CDMO for the production of innovative and targeted molecules to treat cancer. The Le Mans site has already benefitted from significant investment. Now, to support f...

NEW DELHI: On May 1, the Indian government opened its vaccination drive against Covid -19 for all above 18 years. India has been inoculating people against Covid-19 since January using two Covid vaccines - Covishield and Covaxin. However, some lingering questions about the vaccines still remain. Here are answers to some of them. What technology has been deployed in the development of two vaccines in India? Covishield vaccine is developed by the Oxford University and AstraZeneca and is manufact...

• Price of vaccines fixed • Educational institutions to remain closed till 23rd • Study says UK variant accounts for 70pc of cases ISLAMABAD: The first batch of over 1.2 million doses of Oxford-AstraZeneca Covid-19 vaccines reached the country on Saturday under the Covax scheme as another 120 people fell victim to the virus. On the other hand, the Drug Regulatory Authority of Pakistan (Drap) has notified a formula to fix prices of Covid-19 vaccines. Meanwhile, all educational institutions...

0 shares Benny Landsman, 4, at Dayton Children’s Hospital April 8, 2021, before surgery to receive the first clinical trial of a new gene therapy for Canavan disease. (Courtesy of the Landsman family/ via Dayton Jewish Observer) Benny Landsman, 4, is prepped for surgery at Dayton Children’s Hospital, April 8, 2021. (Courtesy of the Landsman family/ via Dayton Jewish Observer) Benny Landsman with Paola Leone and Dr. Christopher G. Janson at Dayton Children’s Hospital, April 8, 2021. ...

No Jab for Me – And Here Are 35 Reasons Why Big Pharma-funded CDC, in 2016 alone,  VAERS (Vaccine Adverse Event Reporting System) received 59,117 vaccine adverse event reports. Among those reports were 432 vaccine-related deaths, 1,091 permanent vaccine-related disabilities, 4,132 vaccine-related hospitalizations, and10,274 vaccine-related emergency room visits. What if these numbers actually represent less than 1% of the total as this report asserts? You multiply those numbers by 100.” �...

By Marshall Weiss, The Dayton Jewish Observer (reprinted with permission) | May 06, 2021 In an operating room at Dayton Children’s Hospital on April 8, 4-year-old Benny Landsman of Brooklyn received the first new clinical trial of an FDA-approved gene therapy for Canavan disease. Neurosurgeon Dr. Robert Lober placed four catheters in holes drilled into Benny’s skull, down a track to a fluid space in the brain’s ventricles. Lober then manually injected a fluid containing 370...

Research says benefits of continuing immunization of front-line workers in BC with AstraZeneca vaccine far outweigh risks Amidst the continued surge of coronavirus disease (COVID-19) cases, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), vaccination efforts continue to mitigate the spread of the virus. Vaccination rollouts have commenced in many countries. One of the vaccines approved via an emergency use authorization (EUA) by the Food and Drug Administration (FDA) ...

Used blood thinner heparin, which they believe adds to the complications. >> that would be a mistake in this situation, because it could be dangerous and make the situation much worse. >> reporter: health officials say that these rare immune responses have only been seen in viral vector vaccines. johnson & johnson is one. astrazeneca is another. pfizer and moderna use a different technology. very quickly today, the federal government put a hold on using the shot at mass vaccination sites and sta...